Home › Von Hippel-Lindau Disease
Von Hippel-Lindau Disease clinical trials recruiting in the U.S.
7 studies for Von Hippel-Lindau Disease are recruiting participants at sites across the United States.
Von Hippel-Lindau disease (VHL) is a rare, genetic disease that causes tumors and cysts to grow in your body.
Cities with the most studies
By state
Recently updated studies
National Eye Institute Biorepository for Retinal Diseases
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 120 · All sexes · Updated Sep 28, 2026 · NCT01496625Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT04924075Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07405164Data Collection Protocol for Patients With Von Hippel Lindau Disease
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT05955014Familial Investigations of Childhood Cancer Predisposition
RecruitingObservational study
All ages · All sexes · Updated Jun 17, 2026 · NCT03050268Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Apr 20, 2026 · NCT04074135MyVHL: Patient Natural History Study
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Apr 26, 2024 · NCT03749980From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.